ZECCHILLO ALESSANDRA

Zecchillo, A., Fiumara, M., Porcellini, S., Canarutto, D., Pedrazzani, G., Pereira, J., et al. (2024). Testing lipid nanoparticles as delivery tool for genome editing of murine haematopoietic stem and progenitor cells. Intervento presentato a: European Society for Gene and Cell Therapy (ESGCT), Roma. Dettaglio

Cappelleri, A., Canesi, S., Bertola, L., Capo, V., Zecchillo, A., Albano, L., et al. (2024). Pneumocystis murina lesions in lungs of experimentally infected Cd40l-/- mice. VETERINARY PATHOLOGY, 61(6), 988-997 [10.1177/03009858241252409]. Dettaglio

Penna, S., Zecchillo, A., Di Verniere, M., Fontana, E., Iannello, V., Palagano, E., et al. (2024). Correction of osteopetrosis in the neonate oc/oc murine model after lentiviral vector gene therapy and non-genotoxic conditioning. FRONTIERS IN ENDOCRINOLOGY, 15 [10.3389/fendo.2024.1450349]. Dettaglio

Zecchillo, A., Milani, M., Iannello, V., di Verniere, M., Draghici, E., Santi, L., et al. (2023). Non-genotoxic conditoning and in vivo gene transfer as new therapeutical approaches for autosomal recessive osteopetrosis. Intervento presentato a: European Society for Gene and Cell Therapy (ESGCT), Bruxelles. Dettaglio

Castiello, M., Di Verniere, M., Draghici, E., Fontana, E., Penna, S., Sereni, L., et al. (2023). Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying Rag1 hypomorphic mutations. FRONTIERS IN IMMUNOLOGY, 14 [10.3389/fimmu.2023.1268620]. Dettaglio